机译:聚乙二醇干扰素α-2a+利巴韦林与聚乙二醇干扰素α-2b+利巴韦林在日本慢性丙型肝炎患者中的随机试验
Department of Gastroenterology and Hepatology, NTT West Kyushu Hospital, 1-17-27 Shinyashiki, Kumamoto, 862-8655, Japan;
Department of Gastroenterology and Hepatology, NTT West Kyushu Hospital, 1-17-27 Shinyashiki, Kumamoto, 862-8655, Japan;
Department of Gastroenterology and Hepatology, NTT West Kyushu Hospital, 1-17-27 Shinyashiki, Kumamoto, 862-8655, Japan;
Department of Gastroenterology and Hepatology, NTT West Kyushu Hospital, 1-17-27 Shinyashiki, Kumamoto, 862-8655, Japan;
Department of Gastroenterology and Hepatology, NTT West Kyushu Hospital, 1-17-27 Shinyashiki, Kumamoto, 862-8655, Japan;
Chronic hepatitis C; Peginterferon α-2a; Peginterferon α-2b; Interleukin-28B;
机译:聚乙二醇干扰素α-2a加利巴韦林与聚乙二醇干扰素α-2b加利巴韦林在日本慢性丙型肝炎患者中的随机试验
机译:聚乙二醇干扰素α-2a和聚乙二醇干扰素α-2b联合利巴韦林对慢性丙型肝炎的疗效和耐受性:随机对照试验的荟萃分析
机译:先前接受聚乙二醇干扰素α-2b+利巴韦林联合治疗失败的患者,用聚乙二醇干扰素α-2a+利巴韦林重新治疗
机译:HCV / HIV与Peginterferon Alfa-2a(40KD)(Pegasys〜R)加上利韦韦林(Copegus〜R)在杏试验期间HCV / HIV CONOMENT患者持续病毒学反应(SVR)的可预测性
机译:利巴韦林在慢性丙型肝炎基因型1感染患者中的群体药代动力学和功效。
机译:聚乙二醇干扰素α-2a和聚乙二醇干扰素α-2b联合利巴韦林对慢性丙型肝炎的疗效和耐受性:随机对照试验的荟萃分析
机译:PGI4系统评价和发表的随机对照试验比较了PEG干扰素-ALPHA-2A与PEG干扰素ALPHA-2B两者加利巴韦林在慢性肝炎患者中的疗效